MEDEZE Partners On Advanced Medical Manufacturing Venture
MEDEZE and Thai health authorities have partnered to establish a biopharmaceutical manufacturing company with 105 million baht in capital, aiming to produce advanced cell therapies locally and reduce treatment costs by 30-50 percent while p
MEDEZE, the Pharmaceutical Organization (Por Ror Sor), and Cretan Associates Limited have signed a memorandum of understanding to establish GPO Medeze Empower Co., Ltd. with initial registered capital of 105 million baht. The company will develop manufacturing facilities for cell culture media and advanced medical products (ATMPs) meeting GMP standards, aiming to reduce reliance on imported raw materials, support biopharmaceutical research and production, and position Thailand as Asia's biopharma and medical innovation hub.
The new company plans to become a Contract Development and Manufacturing Organization (CDMO) for biopharmaceutical products, supporting research development from universities, hospitals, researchers, and biotech companies both domestically and internationally. The initiative targets reducing cell therapy production and treatment costs by 30-50 percent, making quality, internationally-standard medical innovations more accessible to the public.
Dr. Somruk Chungsamnan, Deputy Minister of Public Health, expressed strong support for the partnership, calling it a significant step in public-private collaboration to advance Thailand's advanced medical industry. He emphasized that while Thailand is internationally recognized as a medical hub, the next phase is to transition from providing quality medical services to developing indigenous medical knowledge, technology, and innovation. ATMPs—encompassing cell therapy, gene therapy, and biotechnology—represent crucial future technology that is transforming global disease treatment approaches.
ATMPs offer Thailand opportunities to strengthen health security, reduce dependence on foreign technology, and enhance competitive capacity. Investment in advanced medical technology today is investment in the future, establishing foundations for Thailand to become a genuine Medical Innovation Hub. Officials praised contributions from the Pharmaceutical Organization, MEDEZE Group Public Company Limited, and Cretan Associates in leveraging public and private sector collaboration to create benefits for citizens and build a new future for the country.
